ADMA — ADMA BIOLOGICS INC
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Fundamentals (SEC EDGAR XBRL)
Financials from SEC company facts, point-in-time aligned to each figure’s EDGAR filing date.
| Revenue TTM | Revenue YoY | Net income TTM | Net income YoY | ROE (TTM) | Gross margin | Net margin | P/E (TTM) | P/E pct | P/B | P/B pct |
|---|---|---|---|---|---|---|---|---|---|---|
| $519.2M | +6.3% | $182.4M | -12.9% | 41.6% | 70.8% | 35.4% | — | — | — | — |
Revenue YoY trend Net margin trend
Wall Street Analyst Consensus
Ratings, 12-month price target and EPS forecasts from the Nasdaq public analyst feed. · Fetched 2026-11-19
| Fiscal quarter end | Consensus EPS forecast | Forward P/E | High EPS | Low EPS | # estimates | Revisions (4wk up/down) |
|---|---|---|---|---|---|---|
| Dec 2026 | 0.22 | 15.5× | 0.22 | 0.22 | 1 | — |
| Mar 2027 | 0.16 | 21.3× | 0.16 | 0.16 | 1 | −1 |
| Jun 2027 | 0.18 | 18.9× | 0.18 | 0.18 | 1 | — |
| Sep 2027 | 0.20 | 17.0× | 0.20 | 0.20 | 1 | — |
| Dec 2027 | 0.22 | 15.5× | 0.22 | 0.22 | 1 | — |
| Fiscal year end | Consensus EPS forecast | Forward P/E | High EPS | Low EPS | # estimates | Revisions (4wk up/down) |
|---|---|---|---|---|---|---|
| Dec 2026 | 0.82 | 16.6× | 0.85 | 0.80 | 3 | +2−1 |
| Dec 2027 | 0.86 | 15.8× | 1.07 | 0.74 | 3 | +2−1 |
| Dec 2028 | 2.06 | 6.6× | 2.06 | 2.06 | 1 | +1 |
| Dec 2029 | 2.26 | 6.0× | 2.26 | 2.26 | 1 | +1 |
Forward P/E uses the fetch-time price divided by consensus EPS (quarter annualised ×4). Revision score = (upgrades − downgrades) / estimates, from Nasdaq 4-week counts. Source: Nasdaq analyst data
Last updated: 2026-11-21 · Source: SEC EDGAR Form 13F-HR
As of Q3 2026, 339 SEC-registered investment managers reported holding ADMA (ADMA BIOLOGICS INC) in their latest 13F filings, with a combined reported value of $2.25B across 224.14M shares. That is +7.0% by share count (+13.61M shares) versus the previous quarter, while reported value moved +29.3%. Ownership is concentrated: the five largest holders account for 36.9% of reported value and the top ten for 54.1%.
Compared with the prior quarter, 44 opened new positions, 118 added to existing stakes, 114 trimmed, 40 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q3 2026, not real-time trading.
Major shareholders of ADMA BIOLOGICS INC (ADMA) include Vanguard Group, BlackRock Inc, Sachem Head Capital Management LP, ranked by reported 13F value among the 696 institutional holders on this page.
ADMA is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Legendary Investors Holding ADMA
The superinvestors we track who report ADMA in their latest 13F filing — each shown at that manager’s own most recent quarter.
| Investor | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
|
|
Q3 2026 | 1.65M | $16.54M | 0.13% | Hold |
Which stocks do these investors own together? → · Embed this widget →
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 339 | 224.14M | $2.25B | +6.3% |
| Q2 2026 | 333 | 206.36M | $1.72B | -2.0% |
| Q1 2026 | 371 | 214.85M | $1.92B | +0.1% |
| Q4 2025 | 367 | 232.73M | $4.20B | +6.7% |
| Q3 2025 | 368 | 225.29M | $3.33B | -6.3% |
| Q2 2025 | 374 | 218.79M | $3.94B | +0.8% |
| Q1 2025 | 348 | 213.85M | $4.17B | +0.1% |
| Q4 2024 | 314 | 207.59M | $3.52B | -5.7% |
Over the 8 quarters shown, institutional share counts increased 8% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q4 2025 (+6.7%).
Top Institutional Holders (Q3 2026) — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 37.31M | $374.17M | 0.01% | Reduce | |
| 13.68M | $137.16M | 0.00% | Reduce | |
| 12.35M | $123.90M | 1.17% | Add | |
| 10.04M | $100.71M | 0.06% | Add | |
| 9.47M | $94.97M | 0.00% | Reduce | |
| 9.21M | $92.35M | 0.00% | Reduce | |
| 8.75M | $87.75M | 0.01% | Hold | |
| 8.75M | $87.75M | 0.01% | Hold | |
| 5.92M | $59.34M | 0.00% | Reduce | |
| 5.88M | $58.93M | 3.61% | Add | |
| 5.64M | $56.55M | 0.08% | Add | |
| 5.64M | $56.55M | 0.08% | Add | |
| 3.54M | $35.55M | 0.01% | Reduce | |
| 3.26M | $32.72M | 20.18% | Hold | |
| 2.82M | $28.26M | 0.01% | Reduce | |
| 2.59M | $25.98M | 1.19% | Add | |
| 2.38M | $23.85M | 0.00% | Reduce | |
| 2.34M | $23.49M | 0.00% | Add | |
| 2.34M | $23.49M | 0.00% | Add | |
| 2.21M | $22.19M | 0.59% | Reduce | |
| 2.20M | $22.05M | 0.00% | Reduce | |
| 2.11M | $21.20M | 0.01% | Reduce | |
| 2.10M | $21.05M | 0.00% | Add | |
| 2.10M | $21.05M | 0.00% | Add | |
| 2.04M | $20.51M | 0.01% | Add |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 38.36M | $321.04M | 0.01% | Add | |
| 10.10M | $84.57M | 0.00% | Reduce | |
| 10.09M | $84.44M | 0.00% | Add | |
| 9.34M | $78.17M | 0.72% | Add | |
| 8.76M | $73.29M | 0.01% | Reduce | |
| 8.76M | $73.29M | 0.01% | Reduce | |
| 7.80M | $65.27M | 0.04% | Add | |
| 6.06M | $50.73M | 0.00% | New | |
| 6.06M | $50.73M | 0.00% | Add | |
| 5.27M | $44.15M | 0.02% | Add | |
| 5.27M | $44.15M | 0.06% | Add | |
| 3.61M | $30.18M | 0.01% | Reduce | |
| 3.51M | $29.41M | 0.01% | Add | |
| 3.26M | $27.31M | 12.82% | Add | |
| 3.26M | $27.29M | 0.01% | Reduce | |
| 2.78M | $23.30M | 0.52% | Add | |
| 2.42M | $20.22M | 0.00% | Add | |
| 2.36M | $19.75M | 0.79% | New | |
| 2.27M | $18.96M | 0.00% | Reduce | |
| 2.12M | $17.71M | 1.12% | Reduce | |
| 2.09M | $17.52M | 0.00% | Hold | |
| 2.09M | $17.52M | 0.00% | Hold | |
| 2.09M | $17.52M | 0.00% | New | |
| 2.02M | $16.91M | 0.03% | Reduce | |
| 1.76M | $14.69M | 0.26% | Add |
Q1 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 36.83M | $331.85M | 0.01% | Add | |
| 14.08M | $126.90M | 0.00% | Add | |
| 11.19M | $100.83M | 0.02% | Add | |
| 11.19M | $100.83M | 0.02% | Add | |
| 10.31M | $92.86M | 0.00% | New | |
| 8.87M | $79.91M | 0.00% | New | |
| 6.10M | $54.95M | 0.01% | Add | |
| 5.82M | $52.48M | 0.00% | Hold | |
| 5.01M | $45.10M | 0.01% | Add | |
| 4.79M | $43.15M | 0.02% | Reduce | |
| 4.12M | $37.12M | 0.01% | Reduce | |
| 4.00M | $36.02M | 0.00% | Add | |
| 3.43M | $30.94M | 0.01% | Add | |
| 3.43M | $30.94M | 0.04% | Add | |
| 3.21M | $28.90M | 21.43% | Add | |
| 2.80M | $25.26M | 0.01% | Add | |
| 2.43M | $21.93M | 0.00% | Add | |
| 2.34M | $21.13M | 0.01% | Reduce | |
| 2.28M | $20.58M | 1.49% | Reduce | |
| 2.28M | $20.52M | 0.00% | Hold | |
| 2.22M | $19.97M | 0.00% | Add | |
| 2.15M | $19.37M | 0.01% | Reduce | |
| 2.10M | $18.88M | 0.00% | Reduce | |
| 2.10M | $18.88M | 0.00% | Reduce | |
| 2.09M | $18.85M | 0.03% | Add |
Q4 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 36.33M | $662.72M | 0.02% | Add | |
| 20.85M | $380.39M | 0.01% | Reduce | |
| 13.60M | $248.01M | 0.01% | Hold | |
| 11.79M | $214.96M | 0.03% | Reduce | |
| 11.38M | $207.48M | 4.87% | Add | |
| 6.99M | $127.55M | 0.53% | Add | |
| 6.64M | $121.07M | 0.02% | Add | |
| 6.64M | $121.07M | 0.02% | Add | |
| 5.93M | $108.10M | 0.03% | Add | |
| 5.83M | $106.37M | 0.01% | Hold | |
| 5.20M | $94.82M | 0.05% | Add | |
| 4.84M | $88.20M | 0.02% | Add | |
| 4.57M | $83.34M | 0.05% | Add | |
| 3.94M | $71.82M | 0.03% | Add | |
| 3.79M | $69.14M | 0.13% | Reduce | |
| 3.01M | $54.95M | 5.16% | Add | |
| 2.79M | $50.96M | 0.02% | Reduce | |
| 2.46M | $44.83M | 33.10% | Add | |
| 2.30M | $41.97M | 2.88% | Reduce | |
| 2.27M | $41.35M | 0.01% | Reduce | |
| 2.26M | $41.18M | 0.01% | Reduce | |
| 2.26M | $41.18M | 0.01% | Reduce | |
| 2.20M | $40.13M | 3.88% | Hold | |
| 2.16M | $39.41M | 0.00% | Hold | |
| 2.10M | $38.34M | 0.22% | New |
Q3 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 35.63M | $522.36M | 0.01% | Reduce | |
| 20.97M | $307.49M | 0.01% | Reduce | |
| 13.56M | $198.81M | 0.01% | Add | |
| 12.51M | $183.33M | 0.03% | Reduce | |
| 8.96M | $131.35M | 3.71% | New | |
| 2.84M | $104.30M | 0.03% | Add | |
| 5.81M | $85.24M | 0.01% | Reduce | |
| 5.72M | $83.92M | 0.02% | Add | |
| 5.11M | $74.87M | 0.31% | New | |
| 4.80M | $70.34M | 0.01% | Add | |
| 4.70M | $68.84M | 0.04% | Add | |
| 4.14M | $60.72M | 0.12% | Add | |
| 3.25M | $47.70M | 0.01% | New | |
| 3.25M | $47.70M | 0.01% | New | |
| 2.91M | $42.67M | 0.02% | Add | |
| 2.77M | $40.61M | 0.05% | Reduce | |
| 2.71M | $39.76M | 1.52% | Reduce | |
| 2.64M | $38.65M | 5.38% | New | |
| 2.41M | $35.37M | 26.02% | Add | |
| 2.36M | $34.61M | 0.00% | Reduce | |
| 2.36M | $34.61M | 0.01% | Reduce | |
| 2.36M | $34.61M | 0.01% | Reduce | |
| 2.34M | $34.32M | 2.39% | Reduce | |
| 2.20M | $32.25M | 3.02% | Hold | |
| 2.16M | $31.60M | 0.00% | Add |
Q2 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 36.47M | $664.18M | 0.02% | Reduce | |
| 21.36M | $389.03M | 0.01% | Add | |
| 12.82M | $233.42M | 0.04% | Hold | |
| 12.08M | $219.95M | 0.01% | Add | |
| 5.91M | $107.69M | 0.01% | Add | |
| 5.56M | $101.30M | 0.03% | Add | |
| 4.76M | $86.73M | 0.02% | Reduce | |
| 4.61M | $83.97M | 0.05% | Add | |
| 3.32M | $60.37M | 0.14% | Add | |
| 3.32M | $59.37M | 0.10% | Add | |
| 3.21M | $58.50M | 0.00% | Reduce | |
| 3.15M | $57.29M | 0.08% | Reduce | |
| 3.14M | $57.10M | 2.49% | Reduce | |
| 2.89M | $52.70M | 0.62% | Reduce | |
| 2.72M | $49.51M | 0.01% | Add | |
| 2.50M | $45.56M | 0.01% | Add | |
| 2.50M | $45.56M | 0.01% | Add | |
| 2.48M | $45.11M | 0.36% | Reduce | |
| 2.44M | $44.49M | 0.01% | Reduce | |
| 2.42M | $44.10M | 0.03% | Reduce | |
| 2.39M | $43.53M | 3.04% | Add | |
| 2.32M | $42.20M | 33.51% | Hold | |
| 2.20M | $40.06M | 4.54% | Reduce | |
| 2.14M | $38.96M | 0.00% | Add | |
| 1.96M | $35.72M | 0.00% | Reduce |
New Positions (Q3 2026)
- HRT FINANCIAL LP 618.32K sh · $6.20M
- PFM Health Sciences, LP 436.80K sh · $4.38M
- CLARK ESTATES INC/NY 278.00K sh · $2.79M
- Bridge City Capital, LLC 265.69K sh · $2.66M
- Weiss Asset Management LP 246.91K sh · $2.48M
- TUDOR INVESTMENT CORP ET AL 147.38K sh · $1.48M
- Legato Capital Management LLC 83.11K sh · $833.56K
- Jain Global LLC 55.88K sh · $560.53K
- Yorktown Management & Research Co Inc 43.50K sh · $436.31K
- City Center Advisors, LLC 37.63K sh · $377.41K
- Magnetar Financial LLC 33.29K sh · $333.94K
- PICTON MAHONEY ASSET MANAGEMENT 23.47K sh · $235.38K
Fully Exited (vs previous quarter)
- GEODE CAPITAL MANAGEMENT, LLC sold 6.06M sh · $50.73M
- Sixth Street Partners Management Company, L.P. sold 2.09M sh · $17.52M
- PSP Investments sold 796.22K sh · $6.66M
- HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND sold 667.00K sh · $5.58M
- Marshall Wace sold 307.25K sh · $2.57M
- DekaBank Deutsche Girozentrale sold 236.18K sh · $2.13M
- Velan Capital Investment Management LP sold 250.00K sh · $2.09M
- Future Fund LLC sold 248.52K sh · $2.08M
- Campbell & CO Investment Adviser LLC sold 224.04K sh · $1.88M
- CreativeOne Wealth, LLC sold 126.93K sh · $1.06M
- Illinois Municipal Retirement Fund sold 118.16K sh · $988.99K
- Jupiter Topco LLC sold 98.26K sh · $821.95K
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BlackRock Inc | 37.31M | 38.36M | 36.83M | 36.33M | 35.63M | 36.47M | 37.29M | 38.15M | 38.27M | — | — | — | — | — | — | — | — | — | — | — |
| STATE STREET CORP | 13.68M | — | 14.08M | 13.60M | 13.56M | 12.08M | 11.44M | 14.87M | 13.00M | 8.06M | 10.55M | 9.48M | 9.60M | — | — | — | — | — | — | — |
| Rubric Capital Management LP | 12.35M | 9.34M | 1.81M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| FIRST TRUST ADVISORS LP | 10.04M | 7.80M | 360.22K | 24.65K | 238.56K | 312.19K | 319.35K | 333.31K | 561.23K | 723.58K | — | — | — | — | — | — | — | — | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 9.47M | 10.10M | 10.31M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 9.21M | 10.09M | 8.87M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Capital Research Global Investors | 8.75M | 8.76M | 11.19M | 6.64M | 3.25M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Capital Research Global Investors | 8.75M | 8.76M | 11.19M | 6.64M | 3.25M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Geode Capital Management | 5.92M | 6.06M | 5.82M | 5.83M | 5.81M | 5.91M | 5.67M | 5.43M | 5.38M | 5.24M | 4.81M | 4.65M | 4.35M | 4.17M | 4.05M | 3.39M | 3.29M | 3.19M | 1.72M | 1.41M |
| Caligan Partners LP | 5.88M | 300.00K | 300.00K | 3.01M | 2.64M | — | — | — | — | — | — | 473.09K | 597.51K | — | — | — | — | — | — | — |
| D. E. Shaw & Co., Inc. | 5.64M | 5.27M | 560.83K | 557.15K | 332.70K | 832.56K | 1.53M | 3.07M | 5.26M | 6.82M | 5.38M | 6.51M | 7.57M | — | — | — | — | — | — | — |
| D. E. Shaw & Co | 5.64M | 5.27M | 560.83K | 557.15K | 332.70K | 832.56K | 1.53M | 3.07M | 5.26M | 6.82M | 5.38M | 6.51M | 7.57M | 8.17M | 8.21M | 8.51M | 5.84M | 4.83M | 1.90M | 89.31K |
| DIMENSIONAL FUND ADVISORS LP | 3.54M | 3.61M | 5.01M | 4.84M | 4.80M | 4.76M | 4.86M | 4.67M | 4.02M | 3.16M | 3.60M | 3.49M | 2.93M | — | — | — | — | — | — | — |
| B Group, Inc. | 3.26M | 3.26M | 3.21M | 2.46M | 2.41M | 2.32M | 2.32M | 2.29M | — | — | — | — | — | — | — | — | — | — | — | — |
| Goldman Sachs Group | 2.82M | 3.51M | 2.80M | 1.07M | 2.91M | 1.82M | 1.77M | 2.70M | 2.61M | 1.03M | 904.07K | 1.73M | 2.25M | 1.07M | 952.38K | 874.49K | 620.21K | 444.80K | 670.22K | 156.22K |
| Nantahala Capital Management, LLC | 2.59M | 2.36M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Northern Trust Corp | 2.38M | 2.42M | 2.28M | 2.27M | 2.36M | 2.44M | 2.59M | 2.58M | 2.43M | 2.07M | 2.11M | 2.20M | 2.18M | 2.16M | 1.85M | 1.65M | 1.58M | 1.60M | 364.25K | 365.41K |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2.34M | 2.09M | 2.10M | 2.26M | 2.36M | 2.50M | 2.46M | 2.44M | 2.40M | 2.15M | 1.78M | 1.64M | 1.61M | — | — | — | — | — | — | — |
| Charles Schwab Investment Management | 2.34M | 2.09M | 2.10M | 2.26M | 2.36M | 2.50M | 2.46M | 2.44M | 2.40M | 2.15M | 1.78M | 1.64M | 1.61M | 569.45K | 562.22K | 486.01K | 478.21K | 477.57K | 69.23K | 69.23K |
| Duquesne Family Office LLC | 2.21M | 2.78M | 1.55M | 252.20K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold ADMA?
As of 2026-Q3, 339 institutional funds reported holding ADMA (ADMA BIOLOGICS INC) in SEC 13F filings, with a combined reported value of $2.25B.
How many shares of ADMA do institutions own?
13F filers reported 224.14M shares of ADMA, worth $2.25B in aggregate at the end of 2026-Q3.
Is institutional ownership of ADMA rising or falling?
Share counts moved +7.0% versus the prior quarter — accumulation.
Who are the top institutional holders of ADMA?
The largest 13F holders are Vanguard Group, BlackRock Inc, Sachem Head Capital Management LP, STATE STREET CORP, WESTFIELD CAPITAL MANAGEMENT CO LP; the top 25 are ranked at the top of this page.
Who are the major shareholders of ADMA BIOLOGICS INC?
The major shareholders of ADMA BIOLOGICS INC (ADMA) by reported 13F value are Vanguard Group, BlackRock Inc, Sachem Head Capital Management LP, STATE STREET CORP, WESTFIELD CAPITAL MANAGEMENT CO LP, among 696 institutional holders.
Which legendary investors own ADMA?
1 of the legendary investors tracked on HoldingsHub report ADMA (ADMA BIOLOGICS INC) in their latest 13F filings, led by Terry Smith. Each is shown at that manager's own most recent quarter.
Do superinvestors agree on ADMA?
1 tracked superinvestors hold ADMA simultaneously — see the consensus page for the stocks they own together.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.